The Valley Desk

NCT04042025 · Interventional trial

Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi

Overall registry status Active not recruiting

Phase 3

Conditions SMA, Spinal Muscular Atrophy Type I, Spinal Muscular Atrophy Type II, Spinal Muscular Atrophy Type III

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov